From The Stage

COVID-19: Testing for the “Cytokine Release Syndrome, CRS”

Posted by / / Biomarkers, Industry Update

New data suggests Cytokine Release Syndrome in patients with severe cases of COVID-19 may cause death. See how BioAgilytix can apply our validated MSD cytokine/chemokine panels to support cytokine monitoring in COVID-19 vaccine & therapeutic programs.

Turning Around a Troubled Study: A Rescue Project Success Story

Posted by / / CRO Selection, Immunogenicity

When you have a program that has stalled or gone off schedule, it is vital to team up with a CRO laboratory that is capable of handling quick turnarounds and rescue projects. We look at an example of how BioAgilytix sprung to action to transform a troubled study.